<?xml version="1.0" encoding="UTF-8"?>
<p id="para140">We don't have many antivirals ready to pull off the shelf. More than 90 
 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978613/" id="interrefs110" xmlns:xlink="http://www.w3.org/1999/xlink">have been approved since 1963</ext-link>, when idoxuridine was authorised for the treatment of herpes simplex, but most are only effective against a single type of virus, making it hard to repurpose them against something new. In addition, because viruses rely on their host for most of their functions, it is challenging to create drugs that kill the invaders without harming us too.
</p>
